Beyond Ablation: A Review of Immune Responses Across Focused Ultrasound Modalities
Cancers · 31.07.2026 · 18 (15) · 2460
DOI: 10.3390/cancers18152460 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 31.07.2026. Verfasst von Carley M Elliott und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Roanoke, VA 24016, USA. Die Arbeit nennt 121 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Focused Ultrasound Foundation, NCI NIH HHS, Virginia Tech Institute for Critical Technology and Applied Science Center for Engineered Health.
Abstract (Originalsprache)
Focused ultrasound (FUS) comprises a diverse group of non-invasive, non-ionizing acoustic technologies that have evolved from tools for localized tissue destruction into platforms capable of influencing complex biological processes. In oncology, growing evidence suggests that the effects of focused ultrasound extend beyond direct tumor treatment to include modulation of the tumor microenvironment and anti-tumor immunity. This review examines the major FUS modalities currently under investigation for cancer therapy, including high-intensity focused ultrasound (HIFU), intrinsic threshold histotripsy, boiling histotripsy, shock-scattering histotripsy, and low-intensity focused ultrasound (LIFU), with emphasis on the distinct physical mechanisms that underlie their biological effects. Although these modalities differ in how they interact with tissue, they share the capacity to alter tumor biology through changes in antigen availability, inflammatory signaling, and immune cell activity. These responses have been associated with enhanced immune recognition of tumors, remodeling of immunosuppressive microenvironments, and improved therapeutic responsiveness in preclinical and emerging clinical studies. As interest in focused ultrasound continues to expand, understanding the relationship between modality-specific bioeffects and downstream immune outcomes has become increasingly important. Collectively, the literature highlights focused ultrasound as a versatile therapeutic platform capable of linking precise local intervention with broader biological and immunological consequences, supporting its continued development as both a tumor-directed and immune-modulating strategy in cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Graduate Program in Translational Biology, Medicine, and Health, Virginia Tech, Roanoke, VA 24016, USA.
- Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Blacksburg, VA 24061, USA.
- Department of Biomedical Engineering and Mechanics, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
- College of Science, Virginia Tech, Blacksburg, VA 24061, USA.
ORCID-Profile: Carley M Elliott, Tamalika Paul, Michaela Hall, Sofia Killar
Förderung
- Focused Ultrasound Foundation
- NCI NIH HHS
- Virginia Tech Institute for Critical Technology and Applied Science Center for Engineered Health
- NIH HHS
- Virginia-Maryland College of Veterinary Medicine
- National Institutes of Health
Zitieren
APA
Elliott, C. M., Paul, T., Hall, M., Killar, S., Vlaisavljevich, E., & Allen, I. C. (2026). Beyond Ablation: A Review of Immune Responses Across Focused Ultrasound Modalities. Cancers, 18(15), 2460. https://doi.org/10.3390/cancers18152460
Vancouver
Elliott CM, Paul T, Hall M, Killar S, Vlaisavljevich E, Allen IC. Beyond Ablation: A Review of Immune Responses Across Focused Ultrasound Modalities. Cancers. 2026;18(15):2460. doi:10.3390/cancers18152460
BibTeX
@article{Elliott2026,
author = {Elliott, Carley M and Paul, Tamalika and Hall, Michaela and Killar, Sofia and Vlaisavljevich, Eli and Allen, Irving C},
title = {Beyond Ablation: A Review of Immune Responses Across Focused Ultrasound Modalities},
journal = {Cancers},
year = {2026},
volume = {18},
number = {15},
pages = {2460},
doi = {10.3390/cancers18152460}
}
EUVIMED